Optimizing Erythropoietin-Stimulating Agents (ESAs): Balancing Hemoglobin Targets and Cardiovascular Safety in Anemia Management
Optimizing Erythropoietin-Stimulating Agents (ESAs): Balancing Hemoglobin Targets and Cardiovascular Safety in Anemia Management Erythropoietin-stimulating agents (ESAs) have revolutionized the management of anemia, particularly in patients with chronic kidney disease (CKD) and cancer. By stimulating red blood cell production, ESAs can alleviate symptoms like fatigue and improve quality of...
0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο
google-site-verification: google037b30823fc02426.html